Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in early-to-mid-stage development for treating certain hematology and genetic diseases. The ...

As for the AI bubble, it is coming up for conversation because it is now having a material effect on the economy at large. Some accounts estimate that AI is driving 90% of US GDP growth, while others ...

Johnson & Johnson JNJ, like any other large drugmaker, boasts a robust R&D pipeline of drugs, with its key focus areas being immunology, oncology and neuroscience. J&J has rapidly advanced its ...

Prime Minister Mark Carney said he is confident that Canadian oil will still be competitive after the removal of Nicolas Maduro from power in oil-rich Venezuela while Conservative Leader Pierre ...

Andreessen Horowitz has raised more than $15 billion — its biggest ever funding haul — with plans to invest in industries including artificial intelligence, defense and biotech. The fresh capital, ...

Perhaps the most consequential change of 2025 was the long-overdue realization that climate alarmism is possibly more dangerous than climate change. When even billionaire Bill Gates, long-time climate ...

Crypto didn’t just have a good year in 2025. It thrived in ways that would have seemed like wishful thinking only a couple of years ago when banks shunned it as a liability, and Gary Gensler’s ...